NASDAQ:ACRS - Aclaris Therapeutics SEC Filings & 10K Form

$1.38
-0.25 (-15.34 %)
(As of 09/19/2019 04:00 PM ET)
Today's Range
$1.36
Now: $1.38
$1.59
50-Day Range
$0.77
MA: $1.05
$2.00
52-Week Range
$0.74
Now: $1.38
$15.98
Volume52,628 shs
Average Volume648,938 shs
Market Capitalization$57.09 million
P/E RatioN/A
Dividend YieldN/A
Beta0.81

SEC Filings

Aclaris Therapeutics (NASDAQ:ACRS) SEC Filings

DateFilerForm TypeView
09/09/2019
6:30 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2019
7:45 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2019
3:22 PM
Aclaris Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
08/08/2019
4:01 PM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
6:18 AM
Aclaris Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G/A
07/30/2019
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
3:33 PM
Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G
07/09/2019
4:11 PM
Aclaris Therapeutics (Subject)
Man Group plc (Filed by)
Form SC 13G
07/03/2019
3:47 PM
Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:46 PM
Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2019
3:44 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
4:01 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
4:52 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
5:31 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
4:47 PM
Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:56 PM
Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:52 PM
Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:51 PM
Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:50 PM
Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:49 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
6:00 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
6:01 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
4:24 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:01 PM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
6:10 AM
Aclaris Therapeutics (Filer)
Form DEFA14A
04/25/2019
6:02 AM
Aclaris Therapeutics (Filer)
Form DEF 14A
04/04/2019
6:06 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2019
3:38 PM
Aclaris Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2019
7:01 AM
Aclaris Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2019
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
5:13 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:12 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:11 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:10 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:09 PM
Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
2:35 PM
Aclaris Therapeutics (Subject)
VIVO VENTURES VII, LLC (Filed by)
Form SC 13D/A
02/08/2019
4:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2019
5:34 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
5:33 PM
Aclaris Therapeutics (Issuer)
Powala Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
5:32 PM
Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
5:31 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
5:30 PM
Aclaris Therapeutics (Issuer)
Fair Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
5:29 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:22 PM
Aclaris Therapeutics (Subject)
Broadfin Capital, LLC (Filed by)
Form SC 13G
01/25/2019
1:12 PM
Aclaris Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G/A
01/18/2019
3:34 PM
Aclaris Therapeutics (Filer)
Form 8-K/A
01/18/2019
1:55 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:33 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
6:07 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
6:16 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
6:34 AM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
6:33 AM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
6:32 AM
Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
6:31 AM
Aclaris Therapeutics (Issuer)
Fair Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
6:29 AM
Aclaris Therapeutics (Issuer)
Powala Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
8:59 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2018
7:54 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
7:54 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
7:53 PM
Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
7:52 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
7:51 PM
Aclaris Therapeutics (Issuer)
Powala Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
7:51 PM
Aclaris Therapeutics (Issuer)
Fair Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
8:02 AM
Aclaris Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
12/03/2018
3:16 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
4:01 PM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2018
3:01 PM
Aclaris Therapeutics (Subject)
D. E. SHAW & CO, L.P. (Filed by)
Form SC 13G
10/31/2018
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2018
9:18 AM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/24/2018
9:13 AM
Aclaris Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G/A
10/23/2018
6:13 PM
Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2018
3:08 PM
Aclaris Therapeutics (Filer)
Form 424B5
10/18/2018
3:01 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2018
7:43 PM
Aclaris Therapeutics (Filer)
Form S-3MEF
10/17/2018
3:04 PM
Aclaris Therapeutics (Filer)
Form 424B5
10/15/2018
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2018
3:37 PM
Aclaris Therapeutics (Issuer)
Tullman Stephen A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2018
4:00 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2018
3:55 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/27/2018
3:46 PM
Aclaris Therapeutics (Issuer)
Tullman Stephen A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
3:55 PM
Aclaris Therapeutics (Issuer)
Tullman Stephen A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
1:24 PM
Aclaris Therapeutics (Filer)
Form D/A
08/03/2018
7:16 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2018
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2018
9:52 AM
Aclaris Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
06/12/2018
5:42 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
6:22 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
2:41 PM
Aclaris Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G/A
05/21/2018
3:06 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
6:34 PM
Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
8:28 AM
Aclaris Therapeutics (Filer)
Form CT ORDER
05/09/2018
3:22 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
3:21 PM
Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
3:20 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Featured Article: Monthly Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel